Before You Sell or Raise — Know Where You Stand.

Pricing is in the low five figures. Final pricing depends on the complexity of the engagement. A short introductory call is the fastest way to confirm fit and get a clear answer.

A full strategic assessment: business plan stress-test (every assumption extracted, benchmarked, and sensitivity-tested), multi-method valuation (DCF, comparable companies where relevant, precedent transactions), red flag identification, and a prioritised strategic action plan. For exit readiness, the action plan focuses on what a buyer will see and what to fix. For fundraise readiness, it focuses on investor positioning and valuation anchoring. The output is a presentation-grade deliverable plus a debrief call.

Yes — and ideally 6–12 months before you go to market. Without an independent valuation, you are negotiating from the buyer's numbers. A pre-sale valuation gives you a defensible price range, identifies the value drivers to emphasise, and flags weaknesses you can address before entering the process. Across transactions at Goldman Sachs, owners who went in with a credible independent valuation consistently achieved better outcomes than those who did not.

Both diagnostics are delivered within 10 business days. The timeline starts from the moment Bonneau Advisory receives your complete financial statements and business plan.

Bonneau Advisory works exclusively with companies in consumer goods, beauty, cosmetics, healthcare, wellness, D2C, and retail. This sector focus means working with the margin structures, valuation benchmarks, and deal comparables specific to your industry — not generic financial analysis applied to any sector.

The diagnostic covers the three core methods used at every top-tier investment bank: discounted cash flow analysis (DCF) with explicit assumptions on discount rate, terminal growth, and free cash flow; comparable company analysis using public market peers, where relevant; and precedent transaction analysis using recent M&A deals in your sector. Triangulating across all three gives you a range, not a single number — which is both more honest and more useful in a negotiation. For situations that require it, additional analyses can be structured on top: LBO analysis (relevant when sponsor buyers are involved), merger model, regression-implied valuation, accretion/value pick, or other bespoke work depending on the transaction context.

Founders, CEOs, and CFOs of established companies with EUR 1-50M in revenue who are preparing for a sale or a capital raise and want an independent assessment before going to market. Bonneau Advisory does not work with pre-revenue startups — the methodology and benchmarks are built for companies with real financial history and operating metrics.

A Big Four firm audits your numbers. A bank runs the sale process. Bonneau Advisory sits in between: strategic assessment and valuation with M&A judgment, delivered at a fraction of what a bank charges, and in days rather than months. For companies with EUR 1-50M in revenue, this is often the only way to get investment bank-grade advice without a EUR 200K+ mandate.

At minimum: your business plan and the last two to three years of financial statements (P&L, balance sheet, cash flow). If available, a financial forecast or budget model is also helpful. All materials are handled under strict NDA. If you are unsure whether your documents are sufficient, the preliminary call will clarify exactly what is needed.

An accountant verifies that your numbers are accurate. Bonneau Advisory tests whether your assumptions are realistic — and what they imply for valuation. The analysis uses M&A-specific methods (DCF, trading comps, precedent transactions) and sector-specific benchmarks that a general-practice auditor does not maintain. The output is not a financial audit; it is an independent assessment of what your business is worth and where the risks are, written for the audience that matters: investors, acquirers, or your own board.